S.T.E.P.S.™: A comprehensive program for controlling and monitoring access to thalidomide
- 1 February 1999
- journal article
- Published by Elsevier BV in Clinical Therapeutics
- Vol. 21 (2), 319-330
- https://doi.org/10.1016/s0149-2918(00)88289-2
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Thalidomide revisited: pharmacology and clinical applicationsExpert Opinion on Investigational Drugs, 1998
- Section Review Pulmonary-Allergy, Dermatological, Gastrointestinal & Arthritis: Thalidomide in autoimmune conditionsExpert Opinion on Investigational Drugs, 1996
- A Pregnancy-Prevention Program in Women of Childbearing Age Receiving IsotretinoinNew England Journal of Medicine, 1995
- Thalidomide in Human Immunodeficiency Virus (HIV) PatientsDrug Safety, 1992
- When a Uniquely Effective Drug is TeratogenicNew England Journal of Medicine, 1989
- Clozapine for the treatment-resistant schizophrenic: results of a US multicenter trialPsychopharmacology, 1989
- Clozapine for the Treatment-Resistant SchizophrenicArchives of General Psychiatry, 1988
- The Saga of ThalidomideNew England Journal of Medicine, 1962
- The Saga of ThalidomideNew England Journal of Medicine, 1962
- Die Thalidomid-Embryopathie*Deutsche Medizinische Wochenschrift (1946), 1962